A new trading day began on Friday, with Viking Therapeutics Inc (NASDAQ: VKTX) stock price down -1.93% from the previous day of trading, before settling in for the closing price of $64.67. VKTX’s price has ranged from $8.28 to $99.41 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged -23.49%. With a float of $100.52 million, this company’s outstanding shares have now reached $109.36 million.
Let’s determine the extent of company efficiency that accounts for 27 employees.
Viking Therapeutics Inc (VKTX) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Viking Therapeutics Inc is 8.18%, while institutional ownership is 68.84%. The most recent insider transaction that took place on Feb 09 ’24, was worth 1,345,500. In this transaction President & CEO of this company sold 45,000 shares at a rate of $29.90, taking the stock ownership to the 2,139,882 shares. Before that another transaction happened on Feb 08 ’24, when Company’s President & CEO sold 269,079 for $26.87, making the entire transaction worth $7,230,784. This insider now owns 2,184,882 shares in total.
Viking Therapeutics Inc (VKTX) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of 63.42 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -23.49% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 40.00% during the next five years compared to -18.89% drop over the previous five years of trading.
Viking Therapeutics Inc (NASDAQ: VKTX) Trading Performance Indicators
Here are Viking Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 19.19.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.91, a number that is poised to hit -0.28 in the next quarter and is forecasted to reach -1.52 in one year’s time.
Technical Analysis of Viking Therapeutics Inc (VKTX)
Looking closely at Viking Therapeutics Inc (NASDAQ: VKTX), its last 5-days average volume was 2.33 million, which is a drop from its year-to-date volume of 5.8 million. As of the previous 9 days, the stock’s Stochastic %D was 7.18%. Additionally, its Average True Range was 5.03.
During the past 100 days, Viking Therapeutics Inc’s (VKTX) raw stochastic average was set at 59.04%, which indicates a significant increase from 9.32% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 37.01% in the past 14 days, which was lower than the 157.02% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $64.45, while its 200-day Moving Average is $27.41. However, in the short run, Viking Therapeutics Inc’s stock first resistance to watch stands at $65.60. Second resistance stands at $67.78. The third major resistance level sits at $69.76. If the price goes on to break the first support level at $61.44, it is likely to go to the next support level at $59.46. Now, if the price goes above the second support level, the third support stands at $57.28.
Viking Therapeutics Inc (NASDAQ: VKTX) Key Stats
With a market capitalization of 6.94 billion, the company has a total of 110,218K Shares Outstanding. Currently, annual sales are 0 K while annual income is -85,900 K. The company’s previous quarter sales were 0 K while its latest quarter income was -24,600 K.
